BBOT to Participate in Upcoming Investor Healthcare Conferences

Rhea-AI Summary

BridgeBio Oncology Therapeutics (Nasdaq: BBOT) will participate in three investor healthcare conferences in September 2026: the Cantor Global Healthcare Conference on September 9 at 9:45 a.m. ET, Citi's Biopharma Back to School Conference on September 10 at 3:00 p.m. ET, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15 at 1:50 p.m. ET.

Live webcasts and 90-day replays will be available via the BBOT investor events webpage.

News Market Reaction – BBOT

+0.79% 1.9x vol

1 alert

+0.79% Session close to close

$738.07M Market Cap

1.9x Rel. Volume

In the Sep 2 session, BBOT gained 0.79%, reflecting a mild positive market reaction. Trading volume was above average at 1.9x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in upcoming investor conferences.

Details of the company’s participation are as follows:

• Cantor Global Healthcare Conference 2026
  Wednesday, September 9, 2026, at 9:45 a.m. ET

• Citi's 2026 Biopharma Back to School Conference
  Thursday, September 10, 2026, at 3:00 p.m. ET

• Morgan Stanley 24th Annual Global Healthcare Conference
  Tuesday, September 15, 2026, at 1:50 p.m. ET
  

Live webcasts of the presentations will be accessible on the “Events” page of the BBOT website at https://investors.bbotx.com/news-events/events. Replays of the webcasts will be available for at least 90 days following the event.

About BBOT
BBOT is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies. BBOT has the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors. For more information, please visit www.bbotx.com and follow us on LinkedIn.

BBOT Contacts:

Investor Contact:
BBOT
Investors@BBOTx.com

Media Contact:
Inizio Evoke Comms
Jake.robison@inizioevoke.com

FAQ

When will BBOT present at the Cantor Global Healthcare Conference 2026?

BBOT is scheduled to present at the Cantor Global Healthcare Conference 2026 on Wednesday, September 9, 2026, at 9:45 a.m. ET. According to BBOT, a live webcast will be available on its investor events page with a replay for at least 90 days.

What is the date and time of BBOT's presentation at Citi's 2026 Biopharma Back to School Conference (Nasdaq: BBOT)?

BBOT will present at Citi's 2026 Biopharma Back to School Conference on Thursday, September 10, 2026, at 3:00 p.m. ET. According to BBOT, investors can access a live webcast and 90-day replay via the company’s investor events webpage.

When is BBOT presenting at the Morgan Stanley 24th Annual Global Healthcare Conference 2026?

BBOT plans to present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 1:50 p.m. ET. According to BBOT, the session will be webcast live and archived online for at least 90 days.

How can investors access the BBOT (BBOT) conference webcasts and replays?

Investors can access BBOT conference webcasts through the “Events” page at https://investors.bbotx.com/news-events/events. According to BBOT, live streams of each presentation will be available, with replay access maintained for at least 90 days after the events.

What type of company is BridgeBio Oncology Therapeutics (BBOT)?

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company focused on small molecule therapeutics targeting RAS and PI3Kα malignancies. According to BBOT, it aims to improve outcomes for patients with cancers driven by these prevalent oncogenes in human tumors.

Where can I find more investor information about BBOT ahead of the September 2026 conferences?

Investors can find more information about BBOT at www.bbotx.com and on its investor site. According to BBOT, additional updates, conference access links, and contacts are available on the “Events” page and through its posted investor relations email.